Open Access
Table 1
Baseline characteristics of real-world patients. Demographics of 18 real-world patients from the TheraBionic registry. All patients had a diagnosis of advanced HCC and received treatment with HCC-specific frequencies.
| Age | Gender | Race | Previous treatment | BCLC stage | Extra hepatic mets | Child-Pugh | α-Fetoprotein ≥ 400 ng/mL | ECOG PS | POD prior to treatment |
|---|---|---|---|---|---|---|---|---|---|
| 58 | M | Caucasian | Yes | C | Yes | A5 | Yes | 1 | Yes |
| 79 | M | Caucasian | Yes | C | Yes | A6 | Yes | 1 | Yes |
| 86 | M | Caucasian | No | C | No | A5 | No | 2 | No |
| 68 | F | Caucasian | Yes | C | Yes | A6 | Yes | 2 | Yes |
| 36 | M | Caucasian | Yes | C | Yes | B8 | No | 2 | Yes |
| 84 | M | Caucasian | Yes | C | No | A6 | No | 3 | Yes |
| 74 | F | Caucasian | Yes | C | Yes | A6 | Yes | 1 | No |
| 79 | M | Caucasian | Yes | C | Yes | B9 | No | 2 | Yes |
| 63 | M | Arab / Saudi Arabia | Yes | C | Yes | C10 | Yes | 3 | Yes |
| 46 | M | Black | Yes | C | Yes | B9 | Yes | 1 | Yes |
| 76 | M | Caucasian | Yes | C | Yes | B7 | Yes | 3 | Yes |
| 70 | F | Caucasian | Yes | C | No | A6 | No | 1 | Yes |
| 46 | M | Caucasian | Yes | C | Yes | A5 | No | 1 | Yes |
| 63 | M | Caucasian | Yes | C | No | A5 | Yes | 2 | Yes |
| 74 | M | Caucasian | Yes | C | Yes | A6 | Yes | 2 | Yes |
| 75 | M | Caucasian | Yes | C | Yes | A6 | No | 2 | Yes |
| 58 | M | Caucasian | Yes | C | Yes | A6 | No | 2 | Yes |
| 72 | M | Hispanic | Yes | D | No | C11 | Yes | 2 | Yes |